Mitochondria are dynamic organelles that continually move and re-shape through mitochondrial fusion and fission, two highly regulated processes that control mitochondrial morphology and ensure mitochondrial function, integrity and oxidative damage repair. Recently, the identity of some of the proteins involved in mitochondrial dynamics in mammalian cells has started to unveil. Mutations in genes encoding for some of these proteins have been shown to be responsible for several human diseases and cellular functions. In fact, mitochondrial dynamics and cell cycle are coupled, and the rate of fusion and fission is regulated during the different phases of the cell cycle, permitting appropriate phase progression and distribution of mitochondria in daughter cells during mitosis. Our group recently identified the polymerase delta interacting protein 2 (Poldip2) as a novel positive regulator of Nox4, and our new preliminary data suggest that Poldip2 controls the expression of the Mitochondria-Localized Glutamic Acid-Rich Protein (MGARP), a protein responsible for mitochondrial movement along the microtubules. These data raise the interesting possibility that Poldip2 participates in the regulation of mitochondrial movement and dynamics, and therefore cell bioenergetics. In this proposal, we will test the hypothesis that Poldip2 controls mitochondrial fission through the regulation of MGARP expression, which subsequently impacts cell cycle progression and proliferation. To address this problem, we will first determine the mechanism by which Poldip2 regulates mitochondrial dynamics. In the second aim, we will establish the functional consequences of Poldip2-mediated regulation of mitochondrial dynamics, focusing on mitochondrial damage repair and oxidative phosphorylation (OXPHOS) capacity and their impact in cell cycle progression. Because VSMC proliferation is known to be a critical component of atherosclerosis, our last aim will be devoted to investigating the role of the Poldip2/MGARP pathway in a model of partial ligation-induced atherosclerosis using inducible smooth muscle specific Poldip2 knockout mice on an ApoE-/- background. This research program will advance our understanding of the interface between mitochondrial dynamics and cell cycle progression, and will provide important insight into the role of two novel proteins in vascular pathology that may represent new targets for intervention.

Public Health Relevance

Abnormal vascular smooth muscle cell (VSMC) proliferation plays an important role in the pathogenesis of atherosclerosis, and during proliferation, VSMCs must adjust bioenergetics through the regulation of mitochondrial dynamics and activity. This project is designed to test the role of two recently identified proteins, polymerase-delta interacting protein (Poldip2) and mitochondria-localized glutamic acid-rich protein (MGARP), in controlling mitochondrial partitioning during cell division and consequently cell proliferation. We will determine how Poldip2 regulates mitochondrial dynamics, investigate the mechanisms by which Poldip2- mediated regulation of mitochondrial dynamics affects cell growth and bioenergetics, and examine the role of Poldip2/MGARP pathway in atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL095070-08
Application #
9271230
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Hasan, Ahmed a K
Project Start
2009-08-13
Project End
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
8
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Paredes, Felipe; Suster, Izabela; Martin, Alejandra San (2018) Poldip2 takes a central role in metabolic reprograming. Oncoscience 5:130-131
Lee, Grace Sanghee; Salazar, Hector F; Joseph, Giji et al. (2018) Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival. Lab Invest :
Simmons, Craig A; Jo, Hanjoong (2018) Editorial: Special Issue on Heart Valve Mechanobiology : New Insights into Mechanical Regulation of Valve Disease and Regeneration. Cardiovasc Eng Technol 9:121-125
Williams, Holly C; Ma, Jing; Weiss, Daiana et al. (2018) The cofilin phosphatase slingshot homolog 1 restrains angiotensin II-induced vascular hypertrophy and fibrosis in vivo. Lab Invest :
Yeligar, Samantha M; Kang, Bum-Yong; Bijli, Kaiser M et al. (2018) PPAR? Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation. Am J Respir Cell Mol Biol 58:648-657
Vukelic, Sasa; Xu, Qian; Seidel-Rogol, Bonnie et al. (2018) NOX4 (NADPH Oxidase 4) and Poldip2 (Polymerase ?-Interacting Protein 2) Induce Filamentous Actin Oxidation and Promote Its Interaction With Vinculin During Integrin-Mediated Cell Adhesion. Arterioscler Thromb Vasc Biol 38:2423-2434
Hernandes, Marina S; Lass├Ęgue, Bernard; Hilenski, Lula L et al. (2018) Polymerase delta-interacting protein 2 deficiency protects against blood-brain barrier permeability in the ischemic brain. J Neuroinflammation 15:45
Okwan-Duodu, Derick; Hansen, Laura; Joseph, Giji et al. (2018) Impaired Collateral Vessel Formation in Sickle Cell Disease. Arterioscler Thromb Vasc Biol 38:1125-1133
Hu, Shuhong; Liu, Yifei; You, Tao et al. (2018) Vascular Semaphorin 7A Upregulation by Disturbed Flow Promotes Atherosclerosis Through Endothelial ?1 Integrin. Arterioscler Thromb Vasc Biol 38:335-343
Heath, Jack M; Fernandez Esmerats, Joan; Khambouneheuang, Lucky et al. (2018) Mechanosensitive microRNA-181b Regulates Aortic Valve Endothelial Matrix Degradation by Targeting TIMP3. Cardiovasc Eng Technol 9:141-150

Showing the most recent 10 out of 125 publications